Rhus verniciflua stokes against advanced cancer: A perspective from the korean integrative cancer center

Journal of Biomedicine and Biotechnology

Volumn 2012, Issue , 2012, Pages

  Choi, Woncheol ^a   Jung, Hyunsik ^a   Kim, Kyungsuk ^a   Lee, Sookyung ^a   Yoon, Seongwoo ^a   Park, Jaehyun ^a   Kim, Sehyun ^b   Cheon, Seongha ^a   Eo, Wankyo ^a   Lee, Sanghun ^a  

^a Kyung Hee University College of Medicine   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PLANT EXTRACT; RHUS VERNICIFLUA EXTRACT; UNCLASSIFIED DRUG; ANGIOGENESIS INHIBITOR; TUMOR MARKER;

ADVANCED CANCER; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; COLORECTAL CANCER; CYTOTOXICITY; DRUG MECHANISM; EPIGASTRIC PAIN; HUMAN; KIDNEY CARCINOMA; KOREA; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; METASTASIS; NONHUMAN; PANCREAS CANCER; PRURITUS; REVIEW; STOMACH CARCINOMA; ADULT; AGED; ANIMAL; CANCER CENTER; CANCER INVASION; CANCER TRANSPLANTATION; FEMALE; MALE; METABOLISM; MIDDLE AGED; MOUSE; NEOPLASM; POISON IVY; TREATMENT OUTCOME;

TOXICODENDRON VERNICIFLUUM;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; CANCER CARE FACILITIES; FEMALE; HUMANS; KOREA; MALE; MICE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOPLASMS; PLANT EXTRACTS; RHUS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84855558437     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2012/874276     Document Type: Review

References (36)

1. Jemal A., Ward E., Hao Y., Thun M., Trends in the leading causes of death in the United States, 19702002 Journal of the American Medical Association 2005 294 10 1255 1259 (Pubitemid 41352114)
2. Beinfield H., Korngold E., Chinese medicine and cancer care Alternative Therapies in Health and Medicine 2003 9 5 38 52
3. Gamble A., Bensky D., Kaptchuk T., Chinese Herbal Medicine: Materia Medica 1993 Seattle, Wash, USA Eastland Press
4. Son Y. O., Lee K. Y., Lee J. C., Jang H. S., Kim J. G., Jeon Y. M., Jang Y. S., Selective antiproliferative and apoptotic effects of flavonoids purified from Rhus verniciflua Stokes on normal versus transformed hepatic cell lines Toxicology Letters 2005 155 1 115 125
5. Jang H. S., Kook S. H., Son Y. O., Kim J. G., Jeon Y. M., Jang Y. S., Choi K. C., Kim J., Han S. K., Lee K. Y., Park B. K., Cho N. P., Lee J. C., Flavonoids purified from Rhus verniciflua Stokes actively inhibit cell growth and induce apoptosis in human osteosarcoma cells Biochimica et Biophysica Acta 2005 1726 3 309 316 (Pubitemid 41668540)
6. Samoszuk M., Tan J., Chorn G., The chalcone butein from Rhus verniciflua Stokes inhibits clonogenic growth of human breast cancer cells co-cultured with fibroblasts BMC Complementary and Alternative Medicine 2005 5, article 5
7. Lee J. C., Lee K. Y., Kim J., Na C. S., Jung N. C., Chung G. H., Jang Y. S., Extract from Rhus verniciflua Stokes is capable of inhibiting the growth of human lymphoma cells Food and Chemical Toxicology 2004 42 9 1383 1388 (Pubitemid 38844855)
8. Won T. H., Seo P. S., Park S. D., Kim D. L., Park J. H., Clinical features in 147 patients with systemic contact dermatitis due to the ingestion of chicken boiled with Japanease lacquer tree Korean Journal of Dermatology 2008 46 6 761 768
9. Park S. D., Lee S. W., Chun J. H., Cha S. H., Clinical features of 31 patients with systemic contact dermatitis due to the ingestion of Rhus (lacquer) British Journal of Dermatology 2000 142 5 937 942 (Pubitemid 30304604)
10. Sminova Z., Choi W. C., Kubasova I., Baryshnikov A., Antitumor efficacy of the allergen-removed extract (ACM909Q) in Rhus verniciflua European Journal of Pharmaceutical Sciences 2002 17 78 79
11. Choi W. C., Lee E. O., Lee H. J., Study on antiangiogenic and antitumor activities of processed Rhus verniciflua Stokes extract Korean Journal of Oriental Physiology Pathology 2006 20 825 829
12. Jung M. H., Lee S. H., Ahn E. M., Lee Y. M., Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway Carcinogenesis 2009 30 4 655 661
13. Nguyen M., Arkell J., Jackson C. J., Human endothelial gelatinases and angiogenesis International Journal of Biochemistry and Cell Biology 2001 33 10 960 970 (Pubitemid 32706688)
14. Moon G., Lee S. H., Park J. H., Effect of allergen removed Rhus verniciflua extract on inhibition of tumor metastasis Journal of Korean Traditional Oncology 2010 15 1 47 61
15. Kim J. S., Park B. Y., Park E. K., Lee H. S., Hahm J. C., Bae K. H., Kim M. Y., Screening of anti-angiogenic activity from plant extracts Korean Journal of Pharmacognosy 2006 37 4 253 257
16. Cheon S. H., Kim K. S., Kim S., Jung H. S., Choi W. C., Eo W. K., Efficacy and safety of Rhus verniciflua stokes extracts in patients with previously treated advanced non-small cell lung cancer Forschende Komplementarmedizin 2011 18 2 77 83
17. Lee S. H., Choi W. C., Yoon S. W., Impact of standardized Rhus verniciflua stokes extract as complementary therapy on metastatic colorectal cancer: a Korean single-center experience Integrative Cancer Therapies 2009 8 2 148 152
18. Kim H. R., Kim K. S., Jung H. S., Choi W. C., Eo W. K., Cheon S. H., A case of recurred hepatocellular carcinoma refractory to doxorubicin after liver transplantation showing response to herbal medicine product, Rhus verniciflua stokes extract Integrative Cancer Therapies 2010 9 1 100 104
19. Lee S. H., Choi W. C., Kim K. S., Park J. W., Yoon S. W., Shrinkage of gastric cancer in an elderly patient who received Rhus verniciflua Stokes extract Journal of Alternative and Complementary Medicine 2010 16 4 497 500
20. Lee S. K., Jung H. S., Eo W. K., Lee S. Y., Kim S. H., Shim B. S., Rhus verniciflua Stokes extract as a potential option for treatment of metastatic renal cell carcinoma: report of two cases Annals of Oncology 2010 21 6 1383 1385
21. Lee S. H., Kim K. S., Choi W. C., Yoon S. W., Successful outcome of advanced pulmonary adenocarcinoma with malignant pleural effusion by the standardized Rhus verniciflua stokes extract: a case study Explore 2009 5 4 242 244
22. Shoemaker R. H., The NCI60 human tumour cell line anticancer drug screen Nature Reviews Cancer 2006 6 10 813 823 (Pubitemid 44450469)
23. Newman D. J., Cragg G. M., Natural products as sources of new drugs over the last 25 years Journal of Natural Products 2007 70 3 461 477 (Pubitemid 46595760)
24. Hirte H. W., Novel developments in angiogenesis cancer therapy Current Oncology 2009 16 3 50 54
25. Song D. G., Lee J. Y., Lee E. H., Jung S. H., Nho C. W., Cha K. H., Koo S. Y., Pan C. H., Inhibitory effects of polyphenols isolated from Rhus verniciflua on Aldo-keto reductase family 1 B10 BMB Reports 2010 43 4 268 272
26. Kim J. H., Jung C. H., Jang B. H., Go H. Y., Park J. H., Choi Y. K., Hong S. I., Shin Y. C., Ko S. G., Selective cytotoxic effects on human cancer cell lines of phenolic-rich ethyl-acetate fraction from Rhus verniciflua Stokes American Journal of Chinese Medicine 2009 37 3 609 620
27. Wagner H., Ulrich-Merzenich G., Synergy research: approaching a new generation of phytopharmaceuticals Phytomedicine 2009 16 2-3 97 110
28. Hanahan D., Weinberg R. A., Hallmarks of cancer: the next generation Cell 2011 144 5 646 674
29. Azam F., Mehta S., Harris A. L., Mechanisms of resistance to antiangiogenesis therapy European Journal of Cancer 2010 46 8 1323 1332
30. Kwak E. L., Bang Y. J., Camidge D. R., Shaw A. T., Solomon B., Maki R. G., Ou S. H. I., Dezube B. J., Jnne P. A., Costa D. B., Varella-Garcia M., Kim W. H., Lynch T. J., Fidias P., Stubbs H., Engelman J. A., Sequist L. V., Tan W., Gandhi L., Mino-Kenudson M., Wei G. C., Shreeve S. M., Ratain M. J., Settleman J., Christensen J. G., Haber D. A., Wilner K., Salgia R., Shapiro G. I., Clark J. W., Iafrate A. J., Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer New England Journal of Medicine 2010 363 18 1693 1703
31. Jubb A. M., Oates A. J., Holden S., Koeppen H., Predicting benefit from anti-angiogenic agents in malignancy Nature Reviews Cancer 2006 6 8 626 635 (Pubitemid 44140860)
32. Deng G., Lin H., Seidman A., Fornier M., D'Andrea G., Wesa K., Yeung S., Cunningham-Rundles S., Vickers A. J., Cassileth B., A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects Journal of Cancer Research and Clinical Oncology 2009 135 9 1215 1221
33. Jeong G. S., Lee D. S., Song M. Y., Park B. H., Kang D. G., Lee H. S., Kwon K. B., Kim Y. C., Butein from Rhus verniciflua protects pancreatic cells against cytokine-induced toxicity mediated by inhibition of nitric oxide formation Biological and Pharmaceutical Bulletin 2011 34 1 97 102
34. Lee J. D., Huh J. E., Jeon G., Yang H. R., Woo H. S., Choi D. Y., Park D. S., Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models International Immunopharmacology 2009 9 3 268 276
35. Lee J., Lim K. T., Plant-originated glycoprotein (36kDa) suppresses interleukin-4 and-10 in bisphenol A-stimulated primary cultured mouse lymphocytes Drug and Chemical Toxicology 2010 33 4 421 429
36. De Monte L., Reni M., Tassi E., Clavenna D., Papa I., Recalde H., Braga M., Di Carlo V., Doglioni C., Protti M. P., Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer Journal of Experimental Medicine 2011 208 3 469 478